Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients
- PMID: 33809063
- PMCID: PMC7998226
- DOI: 10.3390/cancers13061250
Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients
Abstract
The novel coronavirus SARS-CoV-2 is the causative agent of the COVID-19 pandemic. Severely symptomatic COVID-19 is associated with lung inflammation, pneumonia, and respiratory failure, thereby raising concerns of elevated risk of COVID-19-associated mortality among lung cancer patients. Angiotensin-converting enzyme 2 (ACE2) is the major receptor for SARS-CoV-2 entry into lung cells. The single-cell expression landscape of ACE2 and other SARS-CoV-2-related genes in pulmonary tissues of lung cancer patients remains unknown. We sought to delineate single-cell expression profiles of ACE2 and other SARS-CoV-2-related genes in pulmonary tissues of lung adenocarcinoma (LUAD) patients. We examined the expression levels and cellular distribution of ACE2 and SARS-CoV-2-priming proteases TMPRSS2 and TMPRSS4 in 5 LUADs and 14 matched normal tissues by single-cell RNA-sequencing (scRNA-seq) analysis. scRNA-seq of 186,916 cells revealed epithelial-specific expression of ACE2, TMPRSS2, and TMPRSS4. Analysis of 70,030 LUAD- and normal-derived epithelial cells showed that ACE2 levels were highest in normal alveolar type 2 (AT2) cells and that TMPRSS2 was expressed in 65% of normal AT2 cells. Conversely, the expression of TMPRSS4 was highest and most frequently detected (75%) in lung cells with malignant features. ACE2-positive cells co-expressed genes implicated in lung pathobiology, including COPD-associated HHIP, and the scavengers CD36 and DMBT1. Notably, the viral scavenger DMBT1 was significantly positively correlated with ACE2 expression in AT2 cells. We describe normal and tumor lung epithelial populations that express SARS-CoV-2 receptor and proteases, as well as major host defense genes, thus comprising potential treatment targets for COVID-19 particularly among lung cancer patients.
Keywords: COVID-19; alveolar epithelial cells; lung neoplasms; single-cell RNA sequencing.
Conflict of interest statement
C.S.S. and A.E.S. are employees of Johnson and Johnson. H.K. receives research support from Johnson & Johnson. T.C. reports consulting fees from MedImmune/AstraZeneca and Bristol-Myers Squibb, advisory role fees from Bristol-Myers Squibb, MedImmune/AstraZeneca and EMD Serono, and clinical research funding to MD Anderson Cancer Center from Boehringer Ingelheim, MedImmune/AstraZeneca, EMD Serono, and Bristol-Myers Squibb.
Figures




Similar articles
-
Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.Cardiovasc Res. 2020 Aug 1;116(10):1733-1741. doi: 10.1093/cvr/cvaa191. Cardiovasc Res. 2020. PMID: 32638018 Free PMC article.
-
Cellular Tropism of SARS-CoV-2 across Human Tissues and Age-related Expression of ACE2 and TMPRSS2 in Immune-inflammatory Stromal Cells.Aging Dis. 2021 Jun 1;12(3):718-725. doi: 10.14336/AD.2021.0429. eCollection 2021 Jun. Aging Dis. 2021. PMID: 34094637 Free PMC article.
-
Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.Int J Biol Sci. 2020 Sep 30;16(15):3028-3036. doi: 10.7150/ijbs.51234. eCollection 2020. Int J Biol Sci. 2020. PMID: 33061814 Free PMC article.
-
Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.J Pharm Pharm Sci. 2021;24:84-93. doi: 10.18433/jpps31455. J Pharm Pharm Sci. 2021. PMID: 33626315 Review.
-
Expression profiles revealed potential kidney injury caused by SARS-CoV-2: a systematic analysis of ACE2 and clinical lessons learned from this discovery.Aging (Albany NY). 2020 Nov 21;13(8):10821-10832. doi: 10.18632/aging.202224. Epub 2020 Nov 21. Aging (Albany NY). 2020. PMID: 33234728 Free PMC article.
Cited by
-
The Impact of COVID-19 Infection in Cancer 2020-2021.Cancers (Basel). 2022 Nov 29;14(23):5895. doi: 10.3390/cancers14235895. Cancers (Basel). 2022. PMID: 36497376 Free PMC article.
-
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity.Nat Commun. 2021 Jul 14;12(1):4314. doi: 10.1038/s41467-021-24467-0. Nat Commun. 2021. PMID: 34262047 Free PMC article.
-
Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods.Comput Struct Biotechnol J. 2021;19:6229-6239. doi: 10.1016/j.csbj.2021.11.026. Epub 2021 Nov 20. Comput Struct Biotechnol J. 2021. PMID: 34840672 Free PMC article.
-
Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS‑CoV‑2 infected lungs.Mol Med Rep. 2022 Apr;25(4):138. doi: 10.3892/mmr.2022.12654. Epub 2022 Feb 25. Mol Med Rep. 2022. PMID: 35211765 Free PMC article.
References
-
- World Health Organization . Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19), 14–20 Februray 2020. WHO; Geneva, Switzerland: 2020.
-
- Garassino M.C., Whisenant J.G., Huang L.-C., Trama A., Torri V., Agustoni F., Baena J., Banna G., Berardi R., Bettini A.C., et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): First results of an international, registry-based, cohort study. Lancet Oncol. 2020;21:914–922. doi: 10.1016/S1470-2045(20)30314-4. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous